AXAllison W. Xu

Allison W. Xu

*This is an algorithmically generated author record based on publicly available information.

Allison W. Xu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Elizabeth K. Unger

    Departments of Biochemistry and Molecular Medicine, Chemistry, Statistics, Molecular and Cellular Biology, and Physiology and Membrane Biology, the Center for Neuroscience, and Graduate Programs in Molecular, Cellular, and Integrative Physiology, Biochemistry, Molecular, Cellular and Developmental Biology and Neuroscience, University of California, Davis, Davis, CA 95616, USA

    4 shared publications
  • Louise E. Olofsson

    Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden

    4 shared publications
  • James P. Warne

    Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA

    3 shared publications
  • Merisa L. Piper

    UCSF Diabetes Center and the Department of Anatomy, University of California, San Francisco, San Francisco, California 94143

    3 shared publications
  • Martin G. Myers

    Departments of Internal Medicine and Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan

    2 shared publications
  • A. Jamila Newton

    Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA

    1 shared publication

Latest Publications

  • Open Access

    Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance

    by Louise E. Olofsson, Elizabeth K. Unger, Clement C. Cheung, Allison W. Xu

    Significance: Multiple neuronal subtypes are involved in metabolic regulation, but little is known about the temporal dysregulation of neuronal functions upon acute consumption of fat-rich diets. We show that AgRP neurons are the predominant cell type situated outside the blood-brain barrier in the mediobasal hypothalamus. AgRP neurons are able to sense slight changes in plasma metabolic signals, such as leptin, but they also more quickly develop cellular leptin resistance compared with other hypothalamic neurons. We further show that modulation of SOCS3 expression in AgRP neurons plays a dynamic role in metabolic fine tuning in response to acute change of nutritional status.


  • Open Access

    AgRP Innervation onto POMC Neurons Increases with Age and Is Accelerated with Chronic High-Fat Feeding in Male Mice

    by A. Jamila Newton, Simon Hess, Lars Paeger, Merly C. Vogt, Jenifer Fleming Lascano, Eduardo A. Nillni, Jens C. Brüning, Peter Kloppenburg, Allison W. Xu

    In many mammals, body weight increases continuously throughout adulthood until late middle age. The hormone leptin is necessary for maintaining body weight, in that high levels of leptin promote negative energy balance. As animals age, however, their increase in body weight is accompanied by a steady rise in circulating leptin levels, indicating the progressive development of counterregulatory mechanisms to antagonize leptin’s anorexigenic effects. Hypothalamic neurons coexpressing agouti-related peptide (AgRP) and neuropeptide Y are direct leptin targets. These neurons promote positive energy balance, and they inhibit anorexigenic proopiomelanocortin (POMC) neurons via direct neuropeptide action and release of γ-aminobutyric acid. We show here that AgRP and neuropeptide Y innvervation onto POMC neurons increases dramatically with age in male mice. This is associated with progressive increase of inhibitory postsynaptic currents and decrease of POMC firing rate with age. Neuronal activity is significantly attenuated in POMC neurons that receive a high density of AgRP puncta. These high-density AgRP inputs correlate with leptin levels in normal mice and are nearly absent in mice lacking leptin. The progression of increased AgRP innervation onto POMC somas is accelerated in hyperleptinemic, diet-induced obese mice. Together our study suggests that modulation of hypothalamic AgRP innervation constitutes one mechanism to counter the effects of the age-associated rise in leptin levels, thus sustaining body weight and fat mass at an elevated level in adulthood.


  • Investigating Estrogen's Protective Effect on Glucose Homeostasis in a Genetic Model of Hyperglycemia

    by Jamila Newton, James P Warne, Allison W Xu

    Amongst many critical functions in regulating energy balance, leptin receptor-expressing neurons in the brain are also responsible for helping to maintain whole-body glucose homeostasis. In order to better understand how central leptin signaling controls insulin release and sensitivity in the periphery, we performed studies using transgenic mutant mice lacking Stat3 in neurons expressing the long-form leptin receptor (LepRb-Stat3). Though mutants of both sexes are significantly obese, female mutants appear to be protected from the some of the expected comorbidities, including hyperglycemia and decreased longevity observed in male mutants. Male mutants display impaired glucose tolerance and insulin tolerance which worsens during adulthood. Interestingly, though females are able to maintain normal plasma glucose levels throughout life, there is a transient hyperglycemia which occurs during pregnancy. Taken together, the aforementioned data, as well as other experiments which will be presented, suggest that estrogen may act both directly on the pancreas and indirectly through leptin receptor neurons to regulate glucose homeostasis. Sources of Research Support: Hurlbut-Johnson Foundation to A.W.X.; IRACDA fellowship NIGMS 5K12GM081266-02 to A.J.N.; core facilities funded by NIH DERC P30 DK063720. Nothing to Disclose: JN, JPW, AWX

  • Central Cellular Leptin Resistance Can Manifest as Hepatic Steatosis Independent of Obesity

    by James P Warne, Farzad Alemi, Alison S Reed, Helen Chan, Merisa L Piper, Mark E Mullin, Martin G Myers, Carlos U Corvera, Allison W Xu

    Common obesity is associated with the diminished ability of leptin to stimulate signal transduction pathways, such as those utilizing signal transducer and activator of transcription-3 (STAT3) and phosphatidylinositol 3-kinase (PI3K), in neurons expressing the long form of the leptin receptor (LepRb). Such diminished leptin signaling, here termed cellular leptin resistance, can impact the ability of leptin to modulate metabolism. Indeed, we and others (1,2) have previously shown that impaired leptin-stimulated STAT3 signaling results in hyperphagia and profound obesity. In this study, we show that low dose (4μg/day) leptin administration into the lateral ventricle of the adult mouse brain over 7 days significantly reduces liver triglyceride levels without affecting feeding and body adiposity. In order to explore if signaling through PI3K is required for this effect of leptin, leptin-induced PI3K signaling was attenuated by moderate transgenic over-expression of phosphatase and tensin homolog (PTEN) in LepRb-expressing neurons. This transgenic approach results in mice with ~50% reduction in basal PI3K signaling and diminished ability of leptin to signal through PI3K, without affecting basal or leptin-stimulated STAT3 signaling. Mice with reduced PI3K signaling exclusively in LepRb neurons exhibit an increase in the mRNA expression of genes involved in liver de novo lipogenesis and an increase in hepatic triglyceride levels without significant effect on body weight, adiposity, hepatic insulin signaling or hepatic triglyceride release when compared to control littermates. Simultaneous downregulation of PI3K and STAT3 function in LepRb-expressing neurons does not cause further change in adiposity, when compared to mice with STAT3 deletion alone, but results in more severe hepatic steatosis. Increased feeding and body adiposity are commonly considered to be the primary outcomes of leptin resistance with hepatic steatosis presumed to be a secondary consequence of obesity. However, our results strongly suggest that central cellular leptin resistance, when manifested as impaired leptin-induced PI3K signaling, can result in hepatic steatosis independent of hyperphagia and obesity. (1) Bates SH et al., Nature 2003; 421:856 (2) Piper ML et al., Mol Endocrinol 2008; 22:751 Sources of Research Support: NIH grant R01DK080427 awarded to AWX; NIH Pediatric Endocrine Training grant T32DK07161 awarded to ASR; NIH DERC P30 DK063720 supported core facilities. Nothing to Disclose: JPW, FA, ASR, HC, MLP, MEM, MGM, CUC, AWX

  • Open Access

    Functional Role of c-Jun-N-Terminal Kinase in Feeding Regulation

    by Elizabeth K. Unger, Merisa L. Piper, Louise E. Olofsson, Allison W. Xu

    C-Jun-N-terminal kinase (JNK) is a signaling molecule that is activated by proinflammatory signals, endoplasmic reticulum (ER) stress, and other environmental stressors. Although JNK has diverse effects on immunological responses and insulin resistance in peripheral tissues, a functional role for JNK in feeding regulation has not been established. In this study, we show that central inhibition of JNK activity potentiates the stimulatory effects of glucocorticoids on food intake and that this effect is abolished in mice whose agouti-related peptide (AgRP) neurons are degenerated. JNK1-deficient mice feed more upon central administration of glucocorticoids, and glucocorticoid receptor nuclear immunoreactivity is enhanced in the AgRP neurons. JNK inhibition in hypothalamic explants stimulates Agrp expression, and JNK1-deficient mice exhibit increased Agrp expression, heightened hyperphagia, and weight gain during refeeding. Our study shows that JNK1 is a novel regulator of feeding by antagonizing glucocorticoid function in AgRP neurons. Paradoxically, JNK1 mutant mice feed less and lose more weight upon central administration of insulin, suggesting that JNK1 antagonizes insulin function in the brain. Thus, JNK may integrate diverse metabolic signals and differentially regulate feeding under distinct physiological conditions.


  • Open Access

    Functional Role of Suppressor of Cytokine Signaling 3 Upregulation in Hypothalamic Leptin Resistance and Long-Term Energy Homeostasis

    by Alison S. Reed, Elizabeth K. Unger, Louise E. Olofsson, Merisa L. Piper, Martin G. Myers, Allison W. Xu

    OBJECTIVE: Hypothalamic leptin resistance is found in most common forms of obesity, such as diet-induced obesity, and is associated with increased expression of suppressor of cytokine signaling 3 (Socs3) in the hypothalamus of diet-induced obese animals. This study aims to determine the functional consequence of Socs3 upregulation on leptin signaling and obesity, and to investigate whether Socs3 upregulation affects energy balance in a cell type–specific way. RESEARCH DESIGN AND METHODS: We generated transgenic mice overexpressing Socs3 in either proopiomelanocortin (POMC) or leptin receptor–expressing neurons, at levels similar to what is observed in diet-induced obesity. RESULTS: Upregulation of Socs3 in POMC neurons leads to impairment of STAT3 and mammalian target of rapamycin (mTOR)–S6K-S6 signaling, with subsequent leptin resistance, obesity, and glucose intolerance. Unexpectedly, Socs3 upregulation in leptin receptor neurons results in increased expression of STAT3 protein in mutant hypothalami, but does not lead to obesity. CONCLUSIONS: Our study establishes that Socs3 upregulation alone in POMC neurons is sufficient to cause leptin resistance and obesity. Socs3 upregulation impairs both STAT3 and mTOR signaling before the onset of obesity. The lack of obesity in mice with upregulated Socs3 in leptin receptor neurons suggests that Socs3's effect on energy balance could be cell type specific. Our study indicates that POMC neurons are important mediators of Socs3's effect on leptin resistance and obesity, but that other cell types or alteration of other signaling regulators could contribute to the development of obesity.


  • Functional requirement of AgRP and NPY neurons in ovarian cycle-dependent regulation of food intake

    by Louise E. Olofsson, Andrew A. Pierce, Allison W. Xu

    In female mammals including rodents and humans, feeding decreases during the periovulatory period of the ovarian cycle, which coincides with a surge in circulating estrogen levels. Ovariectomy increases food intake, which can be normalized by estrogen treatment at a dose and frequency mimicking those during the estrous cycle. Furthermore, administration of estrogen to rodents potently inhibits food intake. Despite these well-known effects of estrogen, neuronal subtypes that mediate estrogen's anorexigenic effects have not been identified. In this study, we show that changes in hypothalamic expression of agouti-related protein ( Agrp ) and neuropeptide Y ( Npy ) coincide with the cyclic changes in feeding across the estrous cycle. These cyclic changes in feeding are abolished in mice with degenerated AgRP neurons even though these mice cycle normally. Central administration of 17β-estradiol (E2) decreases food intake in controls but not in mice lacking the AgRP neurons. Furthermore, E2 treatment suppresses fasting-induced c-Fos activation in AgRP and NPY neurons and blunts the refeeding response. Surprisingly, although estrogen receptor alpha (ERα) is the key mediator of estrogen's anorexigenic effects, we find that expression of ERα is completely excluded from AgRP and NPY neurons in the mouse hypothalamus, suggesting that estrogen may regulate these neurons indirectly via presynaptic neurons that express ERα. This study indicates that neurons coexpressing AgRP and NPY are functionally required for the cyclic changes in feeding across estrous cycle and that AgRP and NPY neurons are essential mediators of estrogen's anorexigenic function.


  • Open Access

    Specific Physiological Roles for Signal Transducer and Activator of Transcription 3 in Leptin Receptor-Expressing Neurons

    by Merisa L. Piper, Elizabeth K. Unger, Martin G. Myers, Allison W. Xu

    Leptin is a fat-derived hormone that exerts pleiotropic effects on energy balance and neuroendocrine functions. Mice defective in leptin or its receptor [leptin receptor, isoform b (LepRb)] exhibit profound obesity, infertility, and reduced linear growth. Leptin binding to its receptor triggers multiple signaling pathways, including signal transducer and activator of transcription 3 (Stat 3), phosphatidylinositol-3-kinase, and ERK. A considerable amount of effort has been focused on how these signaling pathways mediate diverse leptin functions. Mice containing a mutant LepRb incapable of Stat3 signaling are obese but remain fertile with enhanced linear growth. In contrast, deletion of Stat3 in the whole brain with Nestin-Cre results in infertility and decreased linear growth, in addition to obesity. The additional phenotypes of the Nestin-mediated deletion could reflect Stat3 action in non-LepRb neurons or leptin-independent Stat3 actions in LepRb neurons. To resolve this discrepancy and to gain more insight into the metabolic actions of Stat3, we have generated mice in which Stat3 is disrupted specifically in LepRb neurons after the onset of leptin receptor expression. We show that mutant mice exhibit profound obesity with increased linear growth and normal fertility. In addition, impaired glycemic control in these animals correlates with their degree of obesity. These results demonstrate that Stat3 in LepRb neurons does not regulate linear growth or fertility. These results further suggest that leptin’s effects on growth and reproduction are mediated by other signaling pathways, and that Stat3-mediated control of these functions is mediated independently of leptin and LepRb neurons.


  • Inactivation of Signal Transducer and Activator of Transcription 3 in Proopiomelanocortin (Pomc) Neurons Causes Decreased Pomc Expression, Mild Obesity, and Defects in Compensatory Refeeding

    by Allison W. Xu, Linda Ste-Marie, Christopher B. Kaelin, Gregory S. Barsh

    Leptin is an adipocyte-derived hormone that signals body energy status to the brain by acting on multiple neuronal subgroups in the hypothalamus, including those that express proopiomelanocortin (Pomc) and agouti-related protein (Agrp). Signal transducer and activator of transcription 3 (Stat3) is an important intracellular signaling molecule activated by leptin, and previous studies have shown that mice carrying a mutated leptin receptor that abolished Stat3 binding are grossly obese. To determine the extent to which Stat3 signaling in Pomc neurons was responsible for these effects, we constructed Pomc-specific Stat3 mutants using a Cre recombinase transgene driven by the Pomc promoter. We find that Pomc expression is diminished in the mutant mice, suggesting that Stat3 is required for Pomc transcription. Pomc-specific Stat3 female mutant mice exhibit a 2-fold increase in fat pad mass but only a slight increase in total body weight. Mutant mice remain responsive to leptin-induced hypophagia and are not hypersensitive to a high-fat diet; however, mutant mice fail to mount a normal compensatory refeeding response. These results demonstrate a requirement for Stat3 in transcriptional regulation of Pomc but indicate that this circuit is only one of several components that underlie the neuronal response to leptin and the role of Stat3 in that response.